Total Payments
$8,940
2024 Payments
$650.02
Companies
54
Transactions
565
Medicare Patients
1,678
Medicare Billing
$116,087
Payment Breakdown by Category
Food & Beverage$8,890 (99.4%)
Education$49.78 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,890 | 560 | 99.4% |
| Education | $49.78 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,380 | 82 | $0 (2024) |
| Novo Nordisk Inc | $1,228 | 85 | $0 (2024) |
| Lilly USA, LLC | $709.36 | 48 | $0 (2024) |
| PFIZER INC. | $703.91 | 59 | $0 (2024) |
| Amgen Inc. | $650.71 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $453.23 | 31 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $441.63 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $309.89 | 24 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $304.84 | 15 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $253.08 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $650.02 | 34 | ABBVIE INC. ($138.33) |
| 2023 | $884.39 | 51 | ABBVIE INC. ($388.47) |
| 2022 | $522.18 | 36 | ABBVIE INC. ($288.33) |
| 2021 | $1,027 | 71 | AbbVie Inc. ($218.84) |
| 2020 | $1,013 | 67 | Novo Nordisk Inc ($136.30) |
| 2019 | $1,577 | 89 | Novo Nordisk Inc ($393.25) |
| 2018 | $1,589 | 91 | Novo Nordisk Inc ($195.95) |
| 2017 | $1,677 | 126 | Novo Nordisk Inc ($223.15) |
All Payment Transactions
565 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Oncology | ||||||
| 09/20/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardio-renal | ||||||
| 08/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Cardio-renal | ||||||
| 07/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: ANTIBIOTIC | ||||||
| 06/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 116 | 161 | $27,960 | $8,836 |
| 2022 | 6 | 273 | 348 | $82,915 | $18,757 |
| 2021 | 12 | 647 | 972 | $262,084 | $36,797 |
| 2020 | 14 | 642 | 947 | $238,220 | $51,696 |
Total Patients
1,678
Total Services
2,428
Medicare Billing
$116,087
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 87 | $17,748 | $5,406 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 74 | $10,212 | $3,431 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 165 | $47,307 | $10,197 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 96 | $17,544 | $4,779 | 27.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $14,473 | $2,454 | 17.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 11 | 11 | $2,046 | $765.11 | 37.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $795.42 | $330.16 | 41.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 24 | 25 | $750.00 | $232.74 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 229 | $88,896 | $11,061 | 12.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 153 | 230 | $62,750 | $9,470 | 15.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 131 | 131 | $51,848 | $6,753 | 13.0% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 21 | 84 | $32,676 | $3,606 | 11.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 34 | 34 | $6,657 | $2,219 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 22 | $6,028 | $1,054 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 44 | 78 | $2,340 | $718.54 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 41 | 41 | $2,993 | $652.31 | 21.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 13 | 17 | $3,432 | $650.81 | 19.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 14 | $2,352 | $322.76 | 13.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 12 | 12 | $1,692 | $190.80 | 11.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 14 | 67 | $276.71 | $55.21 | 20.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 12 | 13 | $143.00 | $41.76 | 29.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 127 | 127 | $44,006 | $14,205 | 32.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 202 | $66,250 | $13,184 | 19.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 122 | 194 | $43,830 | $8,411 | 19.2% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2020 | 23 | 127 | $47,902 | $5,968 | 12.5% |
About Dr. Christopher Ehly, MD
Dr. Christopher Ehly, MD is a Adult Medicine healthcare provider based in Prairie Village, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346318417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Ehly, MD has received a total of $8,940 in payments from pharmaceutical and medical device companies, with $650.02 received in 2024. These payments were reported across 565 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($8,890).
As a Medicare-enrolled provider, Ehly has provided services to 1,678 Medicare beneficiaries, totaling 2,428 services with total Medicare billing of $116,087. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Medicine
- Other Specialties Family Medicine
- Location Prairie Village, KS
- Active Since 11/30/2006
- Last Updated 02/02/2024
- Taxonomy Code 207QA0505X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346318417
Products in Payments
- UBRELVY (Drug) $640.39
- Ozempic (Drug) $459.56
- JARDIANCE (Drug) $382.96
- TRULICITY (Drug) $374.58
- Aimovig (Biological) $326.75
- FARXIGA (Drug) $299.67
- VRAYLAR (Drug) $279.84
- Livalo (Drug) $236.32
- CHANTIX (Drug) $229.72
- Saxenda (Drug) $220.47
- XIFAXAN (Drug) $209.87
- Victoza (Drug) $161.74
- Tresiba (Drug) $161.39
- INVOKANA (Drug) $160.83
- SOLIQUA (Drug) $156.63
- MOUNJARO (Drug) $155.34
- Prolia (Biological) $153.93
- ELIQUIS (Drug) $147.02
- Kerendia (Drug) $139.76
- XARELTO (Drug) $130.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.